@article{ee49ab2463d240c7a211cde553ea53ab,
title = "Novel ophthalmic therapeutic modalities based on noninvasive light-targeted drug delivery to the posterior pole of the eye",
keywords = "Age-related macular degeneration, Choroidal neovascularization, Drug delivery, Eye, Laser, Liposomes, Photodynamic",
author = "R. Zeimer and Goldberg, {M. F.}",
note = "Funding Information: The material presented here is the product of efforts by the many collaborators who appear as authors in the cited references. The preparation of this review was made possible by the support of PhotoVision Pharmaceuticals, Inc, Jenkintown, PA. Funding Information: Supported by Research Grants EY 07768, EY 10017 and Core Grant EY 1765 from the National Institutes of Health, Bethesda, Maryland, the Lew R. Wasserman Merit Award, an Alcon Research Institute Award, and an unrestricted research grant from Research to Prevent Blindness, Inc., New York, NY. ",
year = "2001",
month = oct,
day = "31",
doi = "10.1016/S0169-409X(01)00194-6",
language = "English (US)",
volume = "52",
pages = "49--61",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "1",
}